Rodgers & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Rodgers & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-446	Closed	-$258K	–	109
2025 Q4	$258K	Hold	446	–	–	0.03%	89
2025 Q3	$216K	Sell	446 -50	-10%	-$23.3K	0.02%	99
2025 Q2	$201K	Sell	496 -23	-4%	-$9.62K	0.02%	102
2025 Q1	$258K	Sell	519 -57	-10%	-$30.9K	0.03%	80
2024 Q4	$300K	Sell	576 -10	-2%	-$5.5K	0.04%	77
2024 Q3	$362K	Buy	586 +10	+2%	+$5.92K	0.04%	76
2024 Q2	$319K	Buy	576 +190	+49%	+$109K	0.04%	75
2024 Q1	$224K	Sell	386 -110	-22%	-$61.7K	0.03%	80
2023 Q4	$263K	Sell	496 -68	-12%	-$32.9K	0.04%	77
2023 Q3	$285K	Buy	+564	New	+$301K	0.04%	74
2023 Q2	–	Sell	-369	Closed	-$213K	–	86
2023 Q1	$213K	Sell	369 -90	-20%	-$50.7K	0.03%	83
2022 Q4	$253K	Sell	459 -30	-6%	-$15.9K	0.04%	74
2022 Q3	$248K	Hold	489	–	–	0.04%	72
2022 Q2	$266K	Sell	489 -225	-32%	-$124K	0.05%	76
2022 Q1	$422K	Sell	714 -45	-6%	-$25.9K	0.06%	68
2021 Q4	$506K	Buy	+759	New	+$474K	0.08%	67

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rodgers & Associates's TMO Position: Q1 2026 in Review

Rodgers & Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 446 shares — an estimated $258K sold.

Rodgers & Associates first reported a position in TMO in Q4 2021 and held it in 16 quarters. The position peaked at $506K in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Rodgers & Associates reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Rodgers & Associates sold 446 Thermo Fisher Scientific shares in Q1 2026, an estimated $258K.
Rodgers & Associates first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 16 quarters.
Rodgers & Associates's Thermo Fisher Scientific position peaked at $506K in Q4 2021.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Rodgers & Associates's 13F filing for Q1 2026, filed 4 May 2026.